Ranbaxy Recalls Generic Lipitor In US For Possible Presence Of Glass Particle
By Sreeja V N | November 23, 2012 10:02 PM EST
Ranbaxy Laboratories Ltd, India’s largest drug manufacturer by sales, has announced a voluntary recall of its cholesterol-lowering generic drug -- Lipitor -- from the U.S. market.
Ranbaxy’s U.S. wing, Ranbaxy Pharmaceuticals Inc, has recalled various batches of the Atorvastatin calcium tablets -- a generic version of the Lipitor drug -- from the market, the company has said in a statement.
“Ranbaxy Pharmaceuticals Inc. is conducting a voluntary recall for Atorvastatin calcium tablets, in connection with its 10mg 20mg and 40mg dosage strengths, packaged in 90’s and 500 count bottles and only with respect to certain select lot numbers. The recall does not affect or relate to the 80mg strength,” according to a statement on the company’s website.
Ranbaxy was the first company to launch the generic version of the Lipitor after Pfizer Inc's patent expired in November, 2011. The drug was responsible for generating $600 million in sales for the company.
Ranbaxy had compliance issues with the U.S. Food and Drug Administration (FDA) in the past. The FDA banned shipments from some of Ranbaxy’s manufacturing units in 2009 following which the company agreed to take corrective steps in its plants, Reuters reported.
However, industry experts have said that the current recall indicates that such corrective measures are not adequate and the recall will affect the company’s revenues.
"The development will impact the company's credibility to an extent," said Bhagwan Singh Chaudhary, a research associate at the brokerage IndiaNivesh
"There have been issues in the past (about compliance) and a recall suggests, corrective measures suggested by the US FDA are not being implemented," he added, according to Reuters.
However, Ranbaxy said that the recall was being done keeping customers’ safety in mind and the FDA had full knowledge of the issue.
“The recall is being conducted at the retail level for such select batches that may contain a foreign substance (small glass particles approximately less than 1mm in size). Ranbaxy is proactively recalling the drug product lots out of an abundance of caution, and in keeping the safety of our customers in mind. This recall is being conducted with the full knowledge of the U.S. FDA,” the company said.
Click here for the complete list of the batches of drug being recalled.
To contact the editor, e-mail:
Most Popular Slideshows
- Prince Harry & Camilla Thurlow Getting Serious, St. Tropez Holiday Before The Prince’s 30th Birthday [PHOTOS]
- 2014 MTV Video Music Awards: Full List Of Winners, Miley Cyrus ‘Wrecking Ball’ Bags Video Of The Year [PHOTOS]
- Manny Pacquiao Vs. Chris Algieri World Tour Kick Off Press Conference In Macau [PHOTOS]
- Top 5 Richest Tennis Athletes
Join the Conversation
- ‘Days Of Our Lives’ (DOOL) Spoilers For Sept. 1-5: Updates On Kristen, Brady, Theresa, Sami, EJ, Aiden, Hope And More
- A Virtual Toddler Who Behaves And Learns Like Humans
- Suspended Wideout Josh Gordon Cannot Play in Canadian Football League
- Adrian Peterson Wants To Play For Dallas Cowboys – Jerry Jones
- 2014 FIBA Basketball World Cup Scouting Report and Prediction: France National Team
- Sept 19 iPhone 6 Release Date Confirmed as Apple Sets Sept 9 iWatch, 2 iPhones Intro - Report
- Why Moto X is Not the Best Smartphone to Purchase Now?
- Nexus 6 Release Date Will Intro Android 5.0 aka Lemon Meringue Pie with Killer Specs & Features
- Hundreds of Men Rape Teen for Three Years
- Samsung Galaxy S5 Mini vs. LG G3 S (aka LG G3 Beat, LG G3 Mini) – Specs, Features And Price Showdown
- iPhone 6 Release Date Update: 4.7-Inch Model Scores 65.8% In Screen-To-Size Ratio; A Surprise Entry Scales Top Spot [List Attached]
- Product Recall Alert: Hewlett-Packard Pulls Out 6M Power Cords from US, Canada Over Fire Hazard Concerns, Australia Also Affected